Article Details
Retrieved on: 2024-07-22 00:58:20
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Mesoblast's Phase 3 trial for rexlemestrocel-L, a regenerative cell therapy for chronic low back pain. This aligns with 'regenerative medicine' and tags including 'Pain', 'Stem cells', and 'Back pain', showcasing advancements in pain management through regenerative biomedicine.
Article found on: quantisnow.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here